Jennifer McClure, PhD, is a senior investigator and clinical psychologist whose research focuses on developing new interventions to reduce people’s risk of chronic disease and cancer or help them better manage existing chronic disease. Her work includes:
She also serves as Kaiser Permanente Washington Research Institute (KPWHRI)’s director of research, faculty, and development. In this role, Dr. McClure helps set the strategic vision for the institute, oversee policies and procedures relevant to the faculty, and ensure the institute’s financial growth and stability.
Much of Dr. McClure’s research emphasizes creating highly individualized behavioral treatments that can be disseminated on a population level, through health care systems and tobacco quitlines or directly to individuals via the internet and mobile health (mHealth) apps. Her goal is to design programs that are effective, convenient, engaging, and cost-effective, understanding that to make the leap from research to real world, interventions should meet these criteria.
Dr. McClure is best known for her research creating novel treatments for nicotine dependence, particularly interventions targeted to smokers who are ambivalent about quitting. These individuals may want to quit smoking eventually, but are not yet ready to give up tobacco. Most smokers fall into this category, but few interventions are targeted to this important group. Her research has demonstrated the effectiveness of using proactive counseling and online interventions to motivate and support smoking cessation among ambivalent smokers. Her work has also shed light on the potential risks and benefits of using biological indicators of disease or disease risk to motivate quitting. Now she is developing a new mHealth app to help ambivalent smokers kick the habit.
In other current work, Dr. McClure is examining smokers’ dual use of tobacco and marijuana—a growing public health problem as legalization of cannabis spreads. Her collaborative research covers a range of topics from reducing sedentary behavior to comparing the effectiveness of various strategies for assessing and diagnosing high blood pressure.
In recognition of her scientific contributions, Dr. McClure was named a fellow in the Society of Behavioral Medicine (SBM) in 2013 and a fellow in the Society for Research on Nicotine and Tobacco in 2018. Dr. McClure is an affiliate professor of health services at the University of Washington School of Public Health and an affiliate investigator in the Division of Public Health Sciences at the Fred Hutchinson Cancer Research Center. In 2008 she was named KPWHRI’s associate director of research. She assumed her role as director of research, faculty, and development in 2013.
Tobacco cessation; pharmocogenomics of nicotine addiction; treatment adherence; population-based behavior interventions; health risk communications; oral health promotion; dietary change; physical activity promotion; and informed decision-making
Development of eHealth and mHealth intervention tools
Depression treatment and development of behavior change interventions for people with serious mental illness
Prevention and treatment
McClure JB, Catz SL, Brantley PJ. Early appointment adherence among persons living with HIV. AIDS and Behavior. 1999;3(2):157-165.
McClure JB, Wetter DW, deMoor C, Cinciripini PN, Carmack CL, Gritz ER. Alcohol use and tobacco abstinence. Ann Behav Med. 1999;21:S162.
Wetter DW, McClure JB. Smoking cessation: research and clinical strategies. Highlights in Oncology Practice. 1999;16(4):86-90.
McClure JB. Abstinence rates achieved with buproprion corrected. Oncology (Huntingt). 1998;12(9):1303. PubMed
Cinciripini PM, McClure JB. Smoking cessation: recent developments in behavioral and pharmacologic interventions. Oncology (Huntingt). 1998;12(2):249-56, 259; discussion 260, 265, .,. PubMed
Catz SL, McClure JB, Jones GN, Brantley PJ. Factors associated with HIV outpatient nonadherence. Ann Behav Med. 1998;20 (Suppl):S49.
Cinciripini PM, Wetter DW, McClure JB. Scheduled reduced smoking: effects on smoking abstinence and potential mechanisms of action. Addict Behav. 1997;22(6):759-67. PubMed
Skaar KL, Tsoh JY, McClure JB, Cinciripini PM, Friedman K, Wetter DW, Gritz ER. Smoking cessation. 1: An overview of research. Behav Med. 1997;23(1):5-13. PubMed
Tsoh JY, McClure JB, Skaar KL, Wetter DW, Cinciripini PM, Prokhorov AV, Friedman K, Gritz E. Smoking cessation. 2: Components of effective intervention. Behav Med. 1997;23(1):15-27. PubMed
McClure JB, Skaar K, Tsoh J, Wetter DW, Cinciripini PM, Gritz ER. Smoking cessation. 3: Needed healthcare policy changes. Behav Med. 1997;23(1):29-34. PubMed
Dr. Jennifer McClure shares advice and resources for staying physically and emotionally well during the COVID-19 crisis, and beyond.
As Dr. Jennifer McClure completes the last of three innovative studies, she reflects on how the work began, the difference it may make, and what happens next.
Tobacco remains a public health priority. Dr. Jennifer McClure discusses her new findings comparing ’acceptance and commitment therapy’ to standard care.
Dr. Jennifer McClure applauds the American Cancer Society’s recent strike against tobacco that burns. And she unpacks its evidence-based stance on e-cigarettes.
Dr. Jennifer McClure reflects on using personalized genetic knowledge to improve health and health care.